AI model predicts drug properties to speed up development
- A University of Waterloo research team has developed a generative artificial intelligence model to enhance drug development.
- The new AI model aims to speed up the process of creating new drugs.
- This advancement could lead to faster availability of medications.
- The initiative reflects significant advancements in the application of AI in pharmaceutical research.
9 Articles
9 Articles


University of Waterloo creates AI model to speed up drug development
University of Waterloo researchers have developed Imagand, a generative AI model for fast drug discovery, predicting drug properties accurately to revolutionize pharmaceutical development.
Artificial Intelligence Spotlights Medication Risks, Improves Drug Safety
A multicenter study led by Cedars-Sinai created a database of adverse medication events--the fourth leading cause of death in the United States and a medical issue costing more than $500 billion annually.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage